OCT4 Immunohistochemistry Is Superior to Placental Alkaline Phosphatase (PLAP) in the Diagnosis of Central Nervous System Germinoma

OCT4 is an 18-kDa POU-domain transcription factor encoded by the POU5F1 gene. Also known as OCT3, OTF3, and POU5F1, OCT4 is involved in the initiation, maintenance, and differentiation of pluripotent and germline cells during normal development. It is expressed in mouse and human embryonic stem and germ cells but absent from all differentiated somatic cell types in vitro and in vivo. OCT4 has been detected in primary testicular germ cell tumors with pluripotent potential: seminoma and embryonal carcinoma. We investigated: 1) whether a similar pattern of expression is present in primary intracranial germinomas; and 2) how OCT4 compares with placental alkaline phosphatase (PLAP) in terms of specificity and sensitivity as a potential diagnostic tool. We examined histologic sections from 25 cases of germinoma in which paraffin blocks with sufficient material were available. All cases were reviewed and sections from 32 different blocks were obtained and immunostained for OCT4 and PLAP. Additionally, 49 primary and metastatic brain tumors that may be potentially confused with germinoma, either clinically or histologically, were investigated for OCT4 expression. All but one germinoma were pure (ie, lacking other germ cell components). Intense and often diffuse nuclear staining was detected in 100% of germinomas. PLAP immunoreactivity was detected in 23 of 25 cases and was absent in the remaining 2 cases. The intensity of OCT4 immunostaining was significantly better than that of PLAP. None of the 49 control cases, which included glioblastoma multiforme, pineoblastoma, pituitary adenoma, malignant lymphoma, metastatic melanoma, capillary hemangioblastoma, meningioma, schwannoma, and a variety of metastatic carcinomas showed immunoreactivity for OCT4. Our study demonstrates that OCT4 is a highly specific and sensitive immunohistochemical marker for primary intracranial germinomas. OCT4 should be part of immunoperoxidase staining panels in which germinoma enters the differential diagnosis.

[1]  J. Richie.  Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. , 2005, The Journal of urology.

[2]  Liang Cheng,et al.  OCT4: A Novel Biomarker for Dysgerminoma of the Ovary , 2004, The American journal of surgical pathology.

[3]  Liang Cheng,et al.  OCT4 Staining in Testicular Tumors: A Sensitive and Specific Marker for Seminoma and Embryonal Carcinoma , 2004, The American journal of surgical pathology.

[4]  J. Kononen,et al.  POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. , 2003, Cancer research.

[5]  Ohr,et al.  Tumors of the testis, adnexa, spermatic cord, and scrotum , 2009, Archives of pathology & laboratory medicine.

[6]  J. Grifo,et al.  Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. , 2000, Molecular human reproduction.

[7]  K. Cooney,et al.  Intracranial germ cell tumors. , 2000, The oncologist.

[8]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[9]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[10]  H. Schöler,et al.  Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation , 1998, Mechanisms of Development.

[11]  K. Artzt,et al.  Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. , 1996, The Journal of biological chemistry.

[12]  H. Schöler,et al.  Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. , 1996, Development.

[13]  K. Stefanaki,et al.  Immunohistochemical expression of placental alkaline phosphatase and vimentin in epithelial ovarian neoplasms. , 1995, Acta oncologica.

[14]  Grigor Km.  A new classification of germ cell tumours of the testis. , 1993 .

[15]  K. Grigor.  A new classification of germ cell tumours of the testis. , 1993, European urology.

[16]  D. Ho,et al.  Primary intracranial germ cell tumor. Pathologic study of 51 patients , 1992, Cancer.

[17]  H. Schöler,et al.  Structure, expression and chromosomal location of the Oct-4 gene , 1991, Mechanisms of Development.

[18]  T. Okai,et al.  Expression of placental alkaline phosphatase in gastric and colorectal cancers: An immunohistochemical study using the prepared monoclonal antibody , 1990, Cancer.

[19]  H. Schöler,et al.  Oct‐4: a germline‐specific transcription factor mapping to the mouse t‐complex. , 1990, The EMBO journal.

[20]  Peter W. J. Rigby,et al.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo , 1990, Nature.

[21]  Hans R. Schöler,et al.  New type of POU domain in germ line-specific protein Oct-4 , 1990, Nature.

[22]  K. Okamoto,et al.  A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells , 1990, Cell.

[23]  H. Schöler,et al.  A family of octamer‐specific proteins present during mouse embryogenesis: evidence for germline‐specific expression of an Oct factor. , 1989, The EMBO journal.

[24]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[25]  L. Staudt,et al.  Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor. , 1989, Science.

[26]  W. Schaffner,et al.  A cloned octamer transcription factor stimulates transcription from lymphoid–specific promoters in non–B cells , 1988, Nature.

[27]  J. Shinoda,et al.  Placental alkaline phosphatase as a tumor marker for primary intracranial germinoma. , 1988, Journal of neurosurgery.

[28]  J. Shinoda,et al.  Immunohistochemical study of placental alkaline phosphatase in primary intracranial germ-cell tumors. , 1985, Journal of neurosurgery.